Therapy for hepatocellular-carcinoma (review)

Area of Science:

• Hepatology
• Surgical Oncology
• Medical Oncology

Background:

• Hepatocellular carcinoma (HCC) is a prevalent global malignancy.
• HCC often develops in patients with hepatic cirrhosis, complicating treatment options.
• Limited high-quality randomized trials exist for HCC therapies.

Purpose of the Study:

• To review current management strategies for hepatocellular carcinoma (HCC).
• To discuss the roles of surgical resection, liver transplantation, and emerging medical treatments.
• To establish a consensus on the optimal place of various therapies in HCC management.

Main Methods:

• Literature review of surgical and medical treatments for HCC.
• Discussion of chemoembolization, percutaneous ethanol injection, and hormonal therapy.
• Synthesis of evidence to form management recommendations.

Main Results:

• Surgery and liver transplantation are key treatment modalities for HCC.
• Nonsurgical options like chemoembolization and percutaneous ethanol injection offer alternatives.
• Hormonal treatments are also considered in the therapeutic landscape.

Conclusions:

• A multimodal approach is essential for effective hepatocellular carcinoma (HCC) management.
• Integrating surgical, transplant, and medical therapies optimizes patient outcomes.
• Further research is needed to refine treatment protocols for hepatoma.